Obesity May Fuel 40% Gap in Black, White Breast Cancer Mortality
Prostate Cancer Cohort Shows Where Active Surveillance Presents Lowest Risk
Dr Deepu Madduri: We Are One Step Closer to a Cure for Myeloma
Social Determinants of Health May Influence Undiagnosed Breast Cancer Risk
Dr Robert Massie: The Human Connection Between Clinician and Patient Is Vital to the Healing Process
Secukinumab Has a Greater Persistence Rate Than Ustekinumab in Psoriatic Arthritis
Study Finds Young People Quit or Reduced Vaping Habits During the Pandemic
Technological Innovations, Challenges to Integration in Parkinson Disease Management
Patients With SMA Have Medical Costs Over 50 Times Higher Than Those of Healthy Patients
Oral Anticoagulants Touted as Having “Excellent Efficacy” in Postoperative Atrial Fibrillation
A Look at the Use of Echocardiography to Assess Macitentan Effects, Predict Mortality in PAH
Dr Mark Wildgust: Updated APOLLO Trial Results Confirm Daratumumab Safety in Multiple Myeloma
Assisted Reproductive Technology Does Not Increase Ovarian Cancer Risk
National Asthma Guidelines Get First Update in 13 Years
How Hand Grip Strength, Body Composition May Influence Health of Patients With OSA
HIV Remains a Top-10 Cause of Death for Some Populations, Despite Overall Mortality Drops
Janssen Seeks FDA Approval of Amivantamab for Metastatic NSCLC With EGFR Exon 20 Insertion Mutations
Dr Paul Zimmet Outlines COVID-19, Diabetes Challenges and Lessons Learned From the Pandemic
Study Examines Trends in Mortality Rates of Multiple Myeloma in US Adults
Study Examines Clinical Implications of Removing Race From eGFR in CKD
What We’re Reading: Biden Calls for 100 Days of Mask-Wearing; Maternal Morbidity Action Plan Unveiled; COVID-19 Relief Talks Held
Considerations for Designing ePRO Interventions for Patients With RRMM
AJMC® in the Press, December 4, 2020
Dr Mark Wildgust on What to Look for From Janssen at ASH
Dr Deepu Madduri Previews Exciting Developments to Come at This Year’s ASH Meeting
Steady Increase Seen in Cardiac Arrest−Related Overdoses During COVID-19 Pandemic
Population Management Tool Reduces Adverse Events of DOACs
AYA Cancer Rates Are Rising, New Study Finds
Contributor: 3 Reasons Employers Should Be Concerned About ACA Repeal
Algorithm Pipeline Aids in Identification of Patients With RA